Navigation Links
Lesotho takes new steps toward HIV/AIDS elimination

WASHINGTON, D.C.February 3, 2014The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is pleased to announce the expansion of its HIV and AIDS treatment and prevention programs in six districts in Lesotho. With support from the U.S. Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), the additional services offered through EGPAF's Strengthening Clinical Services (SCS) project reflect a programmatic shift that will bolster Lesotho's efforts to eliminate HIV and AIDS.

Based on recommendations from PEPFAR, EGPAF now offers a comprehensive HIV/AIDS care and treatment package in the districts of Mokhotlong, Butha Buthe, Maseru, Mafeteng, Mohale's Hoek, and Thaba in Lesotho.

"Lesotho has lagged behind other countries in sub-Saharan Africa in terms of reducing new HIV infections," said Appolinaire Tiam, country director of EGPAF-Lesotho. "This programmatic shift will allow us to accelerate our efforts to prevent new HIV infections and provide HIV care and treatment to those in need."

The comprehensive package of HIV services provided under the programmatic expansion include improved access to HIV testing and counseling, prevention of mother-to-child transmission (PMTCT) of HIV services, early infant diagnosis of HIV, adult and pediatric HIV care and treatment, nutrition programs, tuberculosis prevention and treatment, and health system strengthening.

EGPAF-supported district mentors and facility-level nurses will work directly with the Lesotho Ministry of Health (MOH) at the district and site level to build capacity and strengthen health systems. District mentors will provide technical assistance and offer supportive supervision to health facilities. The district teams will be supported by a team of program advisors composed of of experts in areas related to the new scope of work. In addition, EGPAF will continue to provide vehicle drivers to address logistics and transportation gaps in the six districts it supports.

Lesotho has the third highest HIV/AIDS prevalence rate in the world, with 23 percent of its population currently living with HIV or AIDS. Since 2004, EGPAF has worked with the Lesotho MOH to provide comprehensive HIV testing, treatment, and prevention services.


Contact: Johanna Harvey
Elizabeth Glaser Pediatric AIDS Foundation

Related biology news :

1. Are anti-poaching efforts repeating the mistakes of the war on drugs?
2. Algae to crude oil: Million-year natural process takes minutes in the lab
3. Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential
4. Battle against resistant bacteria takes huge leap forward
5. Rats! Humans and rodents process their mistakes
6. ISFM takes a stand on welfare of unowned cats
7. Studies support population-based efforts to lower excessive dietary sodium intakes
8. Zeal to ensure clean leafy greens takes bite out of riverside habitat in California
9. New lung cancer study takes page from Googles playbook
10. Research secured for the future: Pensoft Publishers takes on CLOCKSS archival technology
11. Activating RNA takes DNA on a loop through time and space
Post Your Comments:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... 24, 2015 Cepheid (NASDAQ: CPHD ) ... the following conference, and invited investors to participate via ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern ... New York, NY      Tuesday, December 1, ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
(Date:11/24/2015)... , November 24, 2015 SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Financial Officer, will participate in the Piper Jaffray 27 th ... NY on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 ...
Breaking Biology Technology: